Literature DB >> 14650453

Myofascial pain response to topical lidocaine patch therapy: case report.

Anthony S Dalpiaz1, T Andrew Dodds.   

Abstract

This is a case from a preliminary open trial to assess the efficacy of topically applied lidocaine patches as an alternative to trigger point injections for myofascial pain. We describe one case in this report that had a dramatic response to the lidocaine patch. Her pain relief increased, pain intensity decreased, and functional capacity increased. Her pain intensity and relief was measured by the Brief Pain Inventory-Short Form (BPI-SF). A quality of life measure was also included in the BPI-SF. While this was a dramatic response to this patient, it is only one case from an open-trial. The response to other patients has varied. The true clinical utility cannot be obtained from this one report, but only after the data have been analyzed from this initial trial. If the data are promising, a randomized, double-blind, crossover trial is planned.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14650453

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  4 in total

1.  A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study.

Authors:  Srinivas Nalamachu; R S Crockett; Arnold R Gammaitoni; Errol M Gould
Journal:  MedGenMed       Date:  2006-08-09

Review 2.  [Myofascial pain syndrome].

Authors:  R Forst; A Ingenhorst
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

3.  Myofascial pain syndrome: a treatment review.

Authors:  Mehul J Desai; Vikramjeet Saini; Shawnjeet Saini
Journal:  Pain Ther       Date:  2013-02-12

Review 4.  The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence.

Authors:  Oscar A de León-Casasola; Victor Mayoral
Journal:  J Pain Res       Date:  2016-02-12       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.